About
A gazette for the science and the market.
BioWeek is a magazine for biotech, pharma, and healthcare. We write what moved a pipeline, a regulator, or a share price this week, and why it matters.
The desks
Pipeline
What the molecule did
Trials, approvals, and the drugs behind them. A readout is not a story until we say what changed for patients, competitors, and the next study.
Markets
What the tape did
Capital, M&A, and what a biotech is worth this week. The number is the start. The piece is why the number moved.
Policy
What the rule did
FDA, Congress, courts, and the agencies that can halt a launch or reopen a market. We write the decision, not the press line.
Science
What the paper did
Mechanisms, platforms, and the research that will still matter after the headline fades. Biology first, then the company that owns it.